Profile
Mr. Robert S.
Huntley, CFA, CPA is a Director at North Star Asset Management, Inc. He joined NSAM in March 2000.
Over the prior 15 years, Mr. Huntley served as a Senior Auditor at Wipfli Ullrich Bertelson LLP, Vice President of Finance at Enzymatic Therapy, Inc. and as a consultant with Kobielak & Associates.
Mr. Huntley is a 1984 graduate of the University of Wisconsin-Green Bay with a BBA Degree in Accounting.
He is a Certified Public Accountant, a Chartered Financial Analyst charterholder and a member of the CFA Institute.
Bob Huntley active positions
| Companies | Position | Start |
|---|---|---|
North Star Asset Management, Inc.
North Star Asset Management, Inc. Investment ManagersFinance NSAM is a long-term investor that tailors each client portfolio to meet their specific needs and objectives through a combination of high quality, consistent growth companies and investment grade fixed income securities. The firm’s equity approach focuses on identifying and investing in consistent growth companies at reasonable prices, which offer above average total return potential. Their fixed income approach focuses on identifying and investing in companies with investment grade rated debt to avoid excessive credit risk. They strive to avoid excess interest rate risk and reinvestment risk through duration management and look to maintain adequate liquidity to ensure flexibility. | Portfolio Manager-Equities | 01/03/2000 |
Former positions of Bob Huntley
| Companies | Position | End |
|---|---|---|
Enzymatic Therapy LLC
Enzymatic Therapy LLC Pharmaceuticals: OtherHealth Technology Manufactures natural medicines and nutritional supplements | Corporate Officer/Principal | - |
Training of Bob Huntley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
North Star Asset Management, Inc.
North Star Asset Management, Inc. Investment ManagersFinance NSAM is a long-term investor that tailors each client portfolio to meet their specific needs and objectives through a combination of high quality, consistent growth companies and investment grade fixed income securities. The firm’s equity approach focuses on identifying and investing in consistent growth companies at reasonable prices, which offer above average total return potential. Their fixed income approach focuses on identifying and investing in companies with investment grade rated debt to avoid excessive credit risk. They strive to avoid excess interest rate risk and reinvestment risk through duration management and look to maintain adequate liquidity to ensure flexibility. | Finance |
Enzymatic Therapy LLC
Enzymatic Therapy LLC Pharmaceuticals: OtherHealth Technology Manufactures natural medicines and nutritional supplements | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Bob Huntley
















